The principal question mark over Covaxin is not that...
spike protein
The fact that a huge majority of SARS-CoV-2 infections...
A stroke of good fortune from a dosing error...
Scientists in the UK and Germany discovered a new...
When exactly the results of phase 3 studies will...
Ramachandran & co.'s work has guided the design of...
They’re easier to manufacture than traditional vaccines, but scientifically...












